ACUTE SEVERE ASTHMA

✓ Medically ReviewedDISEASEID: MDBT0204🚨 TRIAGE: EMERGENCYICD-10: J46

📖

Definition

CLINICAL DEFINITION

A life-threatening exacerbation of asthma characterised by severe bronchospasm, airway inflammation, and mucus plugging that fails to respond to initial standard bronchodilator therapy. It is defined clinically by features such as a peak expiratory flow (PEF) < 50% of predicted or best, respiratory rate ≥ 25 breaths/min, heart rate ≥ 110 beats/min, or oxygen saturation < 92% on room air, and requires immediate emergency intervention to prevent respiratory failure.

IN PLAIN ENGLISH

A sudden, very severe asthma attack that does not get better with standard reliever inhalers. It causes extreme difficulty breathing and is a medical emergency that needs immediate hospital treatment to help the person breathe.

COMMON MISCONCEPTION / WHAT IT DOES NOT MEAN

Acute Severe Asthma is NOT a mild or moderate asthma flare that responds promptly to inhaled short-acting beta-agonists (SABA). It is also distinct from chronic severe asthma, which refers to poor long-term control despite high-dose maintenance therapy, rather than an acute, life-threatening exacerbation.

🔤

Word Breakdown

asthm-

=Greek 'asthma' meaning panting or shortness of breath

-a

=noun-forming suffix

Literal Meaning: A sharp, severe condition of panting or breathlessness

🏷️

Abbreviations

ASA=Acute Severe Asthma — used in emergency and respiratory contexts

PEF=Peak Expiratory Flow — key measurement in assessing severity

SpO2=Oxygen saturation — monitored to assess hypoxaemia

🔄

Synonyms & Variants

Status Asthmaticus›Severe Acute Asthma Exacerbation›

🎯

Category-Specific Context

As a disease state, acute severe asthma represents the extreme end of the asthma exacerbation spectrum. It is classified by acute physiological derangement and failure of initial outpatient management, requiring emergency protocols to reverse airflow obstruction and prevent impending respiratory arrest.

🏥

Clinical Context & Usage

CLINICAL SETTINGS

Emergency DepartmentIntensive Care UnitAcute Medical UnitAmbulance / Pre-hospital Care

USAGE & DOCUMENTATION NOTES

Clinicians document this as 'acute severe asthma' or 'status asthmaticus' in emergency notes. Severity is typically quantified using PEF percentage of predicted, SpO2, and clinical signs like accessory muscle use or silent chest. Notes often track response to back-to-back nebulisers and IV magnesium or hydrocortisone.

🔬

Primary Causes & Pathophysiology

PATHOPHYSIOLOGY

An acute exposure to triggers causes massive release of inflammatory mediators (histamine, leukotrienes, prostaglandins) from mast cells and eosinophils. This leads to intense bronchial smooth muscle contraction, profound mucosal oedema, and hypersecretion of thick mucus, causing severe airway narrowing. The resulting airflow limitation causes air trapping, dynamic hyperinflation, and increased work of breathing. Ventilation-perfusion mismatch leads to hypoxaemia, while initial hyperventilation causes hypocapnia; a normal or rising PaCO2 indicates respiratory muscle fatigue and impending respiratory failure.

PRIMARY CAUSES

Viral respiratory tract infections (e.g., Rhinovirus)

Viral infection triggers intense airway inflammation and hyperresponsiveness, precipitating severe bronchospasm.

Allergen exposure (e.g., pollen, animal dander, mould)

IgE-mediated cross-linking on mast cells causes massive degranulation and acute bronchoconstriction.

Medication non-adherence

Lack of maintenance inhaled corticosteroids leaves underlying airway inflammation uncontrolled, lowering the threshold for severe exacerbation.

Environmental pollutants and irritants

Oxidative stress and direct airway irritation provoke acute inflammatory cascades and smooth muscle contraction.

💊

Drug-Induced Causes

💊 Non-selective beta-blockers (e.g., propranolol) ↗

Mechanism: Blockade of beta-2 receptors in the bronchial smooth muscle prevents endogenous and exogenous catecholamine-induced bronchodilation.

→ Discontinue non-selective beta-blocker; use cardioselective beta-1 blockers if strictly indicated, with close respiratory monitoring.

💊 Non-steroidal anti-inflammatory drugs (NSAIDs) / Aspirin ↗

Mechanism: In susceptible individuals (AERD), COX-1 inhibition shunts arachidonic acid metabolism to the lipoxygenase pathway, overproducing bronchoconstrictor leukotrienes.

→ Avoid NSAIDs and aspirin; use alternative analgesics like paracetamol or COX-2 selective inhibitors if tolerated.

🌍

Epidemiology

Prevalence:Asthma exacerbations account for millions of emergency department visits globally each year. Approximately 5–10% of asthma patients presenting to the ED meet criteria for acute severe or life-threatening asthma.

Age Group:Can occur at any age, but severe exacerbations are particularly common and dangerous in young children (due to smaller airway calibre) and older adults (due to comorbidities and blunted perception of dyspnoea).

Sex Predilection:Equal

Geographic Distribution:Higher rates of severe exacerbations and asthma mortality are observed in low- and middle-income countries, and in marginalised populations within high-income countries, driven by poor access to maintenance inhaled corticosteroids, environmental exposures, and delayed presentation to care.

Red Flags & Triage ★

TRIAGE LEVEL

🚨 EMERGENCY

DO NOT MISS — LIFE-THREATENING PRESENTATIONS

Silent chest, cyanosis, or poor respiratory effort — indicates life-threatening asthma with minimal air movement; requires immediate preparation for intubation and ICU admission.
Normal or rising PaCO2 on ABG — indicates respiratory muscle fatigue and impending respiratory arrest in a patient who should be hypocapnic from hyperventilation; mandates immediate critical care escalation.

URGENT EVALUATION TRIGGERS

Inability to complete sentences in one breath.
Heart rate ≥ 110 beats/min or respiratory rate ≥ 25 breaths/min.
Peak Expiratory Flow (PEF) < 50% of predicted or best.
Oxygen saturation (SpO2) < 92% on room air.

Contraindications & Precautions

CONTRAINDICATIONS

Non-selective beta-blockers — absolute contraindication during an acute attack as they worsen bronchospasm and antagonise rescue beta-agonists.
Sedatives (e.g.
benzodiazepines
opioids) — contraindicated due to the risk of respiratory depression in a patient with impending respiratory failure.

SPECIAL PRECAUTIONS

Avoid excessive oxygen flow rates without monitoring — target SpO2 94–98% to avoid worsening hypercapnia in patients with concurrent COPD or severe fatigue
though hypoxaemia must always be corrected.
Caution with IV magnesium sulfate — monitor deep tendon reflexes and blood pressure
as toxicity can cause hypotension and respiratory muscle weakness.
Careful use of mechanical ventilation — high risk of dynamic hyperinflation (auto-PEEP) and barotrauma; use low respiratory rates and prolonged expiratory times.

Complications

DOWNSTREAM CLINICAL COMPLICATIONS

Pneumothorax — alveolar rupture due to high intra-alveolar pressures from severe air trapping and hyperinflation.
Respiratory failure and arrest — exhaustion of respiratory muscles and severe hypoxaemia/hypercapnia.
Pulmonary interstitial emphysema — air tracking into the lung interstitium from barotrauma.
Hypoxic-ischaemic brain injury — secondary to prolonged hypoxaemia or cardiac arrest.

🔀

Confused With (LASA & DDx) ★

LEXICAL (LASA) — SIMILAR NAMES

Acute COPD Exacerbation

Presents similarly with severe dyspnoea and wheeze; distinguished by patient age, smoking history, chronic productive cough, and lack of full reversibility on spirometry.

Anaphylaxis

Can present with acute wheeze and respiratory distress; distinguished by the presence of mucocutaneous signs (urticaria, angioedema) and cardiovascular collapse.

CLINICAL DIFFERENTIAL DIAGNOSES (DDx)

Acute Pulmonary Oedema (Cardiogenic)

Key Distinguishing Feature: Presence of crackles/crepitations rather than polyphonic wheeze, history of cardiac disease, and response to diuretics/nitrates rather than bronchodilators.

Foreign Body Aspiration

Key Distinguishing Feature: Sudden onset choking episode, unilateral or focal wheeze, and lack of response to asthma medications; confirmed by imaging or bronchoscopy.

Vocal Cord Dysfunction (Inducible Laryngeal Obstruction)

Key Distinguishing Feature: Inspiratory stridor rather than expiratory wheeze, normal PEF or flattened inspiratory loop on flow-volume loop, and no hypoxaemia.

💎

Clinical Pearls

💎

A normal or rising PaCO2 in an acutely breathless asthmatic is a sinister sign. Early in an attack, patients hyperventilate and blow off CO2 (respiratory alkalosis); a normal PaCO2 means they are tiring and retaining CO2, heralding respiratory arrest.

💎

Do not rely solely on wheeze to assess severity. A 'silent chest' with diminished or absent breath sounds indicates such severe airflow obstruction that not enough air is moving to generate a wheeze.

💎

Intravenous magnesium sulfate is a highly effective adjunct for severe exacerbations unresponsive to initial nebulised therapy. It acts as a smooth muscle relaxant by inhibiting calcium uptake.

💎

Always consider and treat for anaphylaxis if the acute severe asthma presentation is accompanied by hypotension, urticaria, or angioedema, as adrenaline is the primary treatment for both.

📝

Example Usage & SOAP

CLINICAL SENTENCE

"The 24-year-old male presented to the ED with acute severe asthma, exhibiting accessory muscle use, a respiratory rate of 30 breaths/min, and a PEF of 35% predicted despite three back-to-back salbutamol nebulisers."

IN A SOAP NOTE

S: 28yo F with known severe asthma presents with worsening dyspnoea and chest tightness for 4 hours. States she 'cannot catch her breath' and is unable to speak in full sentences. Used rescue inhaler 10 times with no relief. O: HR 125 bpm, RR 32/min, BP 135/85 mmHg, SpO2 89% on room air. Tripod position, using accessory muscles. Widespread polyphonic expiratory wheeze, but diminished air entry at the right base. PEF 140 L/min (35% predicted). A: Acute severe asthma exacerbation, impending respiratory fatigue. P: High-flow oxygen via non-rebreather mask to target SpO2 94-98%. Back-to-back nebulised salbutamol 5mg and ipratropium 500mcg. IV hydrocortisone 100mg. Reassess in 20 mins. Prepare for ABG and consider IV magnesium sulfate if no improvement.

DIFFERENTIAL DIAGNOSIS CONTEXT

Differential for acute severe asthma exacerbation: (1) Acute COPD exacerbation — consider in older patients with smoking history and chronic sputum production; (2) Anaphylaxis — look for urticaria, angioedema, or hypotension; (3) Cardiogenic pulmonary oedema — assess for crackles, elevated JVP, and cardiac history; (4) Foreign body aspiration — consider if sudden onset without viral prodrome and unilateral wheeze.

📈

Prognosis

SHORT-TERM OUTCOME

With prompt and aggressive emergency treatment (oxygen, bronchodilators, systemic steroids), most patients improve within 1–4 hours and can be discharged or admitted to a general ward. Delayed treatment significantly increases the risk of ICU admission and mechanical ventilation.

LONG-TERM PROGNOSIS

Patients who survive an episode of acute severe asthma remain at high risk for future life-threatening exacerbations. Long-term prognosis depends on optimising maintenance therapy (e.g., ICS-LABA, biologic therapies), addressing adherence, and managing environmental triggers.

📚

References & Coding

ICD-10 DIAGNOSTIC CODE

J46

LITERATURE CITATIONS & GUIDELINES

[1]Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. 2023.

[2]British Thoracic Society (BTS) / Scottish Intercollegiate Guidelines Network (SIGN). British guideline on the management of asthma. 2019.

[3]National Asthma Council Australia. Australian Asthma Handbook. 2023.

MEDICAL DISCLAIMER — This content is intended for educational purposes and qualified healthcare professionals only. Always refer to current clinical diagnostic criteria, institutional protocols, and official guidelines. Medobo is not responsible for clinical decisions made based on this content.